deltatrials
Completed OBSERVATIONAL NCT03059641

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

Mutation Profile Detection, Therapeutic Resistance and Clonal Evolution Assessed With Liquid Biopsy of Advanced NSCLC Patients in China

Sponsor: Geneplus-Beijing Co. Ltd.

Conditions Adenocarcinoma of Lung Lung Cancer, Nonsmall Cell Lung Neoplasms Squamous Cell Lung Cancer
Updated 14 times since 2017 Last updated: Feb 3, 2020 Started: Feb 22, 2017 Primary completion: Dec 31, 2019 Completion: Jan 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Adenocarcinoma of Lung and Lung Cancer, Nonsmall Cell, this trial is completed. The trial is conducted by Geneplus-Beijing Co. Ltd. and has accumulated 14 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2017 – ~Aug 2017 · 5 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jun 2019 · 10 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Mar 2020 · 8 months · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 9 earlier versions

  1. Mar 2020 — Nov 2020 [monthly]

    Completed

    Status: Recruiting → Completed

  2. Jul 2019 — Mar 2020 [monthly]

    Recruiting

  3. Jun 2019 — Jul 2019 [monthly]

    Recruiting

  4. Aug 2018 — Jun 2019 [monthly]

    Recruiting

  5. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  6. May 2018 — Jun 2018 [monthly]

    Recruiting

  7. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  8. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  9. Mar 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Geneplus-Beijing Co. Ltd.
  • Shanghai Chest Hospital
Data source: Geneplus-Beijing Co. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations